Reinhard Ziebermayr
Krankenhaus der Elisabethinen(AT)
Publications by Year
Research Areas
Colorectal Cancer Treatments and Studies, Neutropenia and Cancer Infections, Cancer Immunotherapy and Biomarkers, Colorectal and Anal Carcinomas, Cancer Treatment and Pharmacology
Most-Cited Works
- → Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis(2008)456 cited
- → Triple-negative breast cancer(2010)142 cited
- → Maintenance treatment with the immunomodulator MGN1703, a Toll-like receptor 9 (TLR9) agonist, in patients with metastatic colorectal carcinoma and disease control after chemotherapy: a randomised, double-blind, placebo-controlled trial(2014)96 cited
- → Maintenance therapy with the TLR-9 agonist MGN1703 in the phase II IMPACT study of metastatic colorectal cancer patients: A subgroup with improved overall survival.(2015)8 cited
- → Comparison of ColoPrint risk classification with clinical risk in the prospective PARSC trial.(2014)5 cited
- → Breast Cancer: Rank Ligand Inhibition(2010)4 cited
- → A subgroup with improved overall survival from the phase 2 IMPACT study: Maintenance therapy of metastatic colorectal cancer patients with the TLR-9 agonist MGN1703.(2015)3 cited
- → Preliminary results of a phase II/III clinical study of the TLR9 agonist MGN1703 in patients with advanced colorectal carcinoma with disease control after first-line therapy: IMPACT study.(2011)2 cited
- → Updated Results of the Randomized Phase 2 Impact Trial: Maintenance with TLR-9 Agonist Mgn1703 Vs Placebo in Patients with Metastatic Colorectal Carcinoma (MCRC)(2013)1 cited